psyllium has been researched along with lovastatin in 2 studies
| Studies (psyllium) | Trials (psyllium) | Recent Studies (post-2010) (psyllium) | Studies (lovastatin) | Trials (lovastatin) | Recent Studies (post-2010) (lovastatin) |
|---|---|---|---|---|---|
| 731 | 177 | 216 | 4,828 | 698 | 873 |
| Protein | Taxonomy | psyllium (IC50) | lovastatin (IC50) |
|---|---|---|---|
| Chain A, Antigen Cd11a (p180) | Homo sapiens (human) | 2.4 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.0261 | |
| Integrin beta-2 | Homo sapiens (human) | 3.09 | |
| Intercellular adhesion molecule 1 | Homo sapiens (human) | 3.78 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 8.753 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 10 | |
| Neutrophil elastase | Homo sapiens (human) | 0.027 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.02 | |
| Integrin alpha-L | Homo sapiens (human) | 3.09 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 8.753 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.02 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0529 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartz, A; Hiatt, J; Schectman, G | 1 |
| Agrawal, AR; Sharma, PL; Tandon, M | 1 |
1 trial(s) available for psyllium and lovastatin
| Article | Year |
|---|---|
Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
Topics: Adolescent; Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Psyllium; Treatment Outcome; Triglycerides | 2007 |
1 other study(ies) available for psyllium and lovastatin
| Article | Year |
|---|---|
Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans.
Topics: Age Factors; Anticholesteremic Agents; Cholesterol; Humans; Hypercholesterolemia; Lovastatin; Middle Aged; Niacin; Patient Compliance; Prospective Studies; Psyllium; Regression Analysis; Treatment Refusal; United States; Veterans | 1993 |